Confirmation of linkage in von Hippel-Lindau disease. 1990

J M Vance, and K W Small, and M A Jones, and J M Stajich, and L H Yamaoka, and A D Roses, and W Y Hung, and M A Pericak-Vance
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.

Von Hippel-Lindau (VHL) disease was initially reported to be linked to the RAF1 oncogene (3p25). We have ascertained and sampled two large multigenerational VHL families for linkage studies, in order to confirm the localization of the VHL gene as a prelude to fine mapping studies. The probes used in the analysis were p627 (RAF1) and pHeA12 (thyroid hormone receptor B) (3p24.1-3p22). VHL was analyzed as an autosomal dominant trait with age-dependent penetrance. The maximum lod score combining both families was z(theta) = 2.16 at theta = 0.0 for RAF1 and z(theta) = 2.20 at theta = 0.05 for thyroid hormone receptor B. Multipoint analysis using the RAF1 and thyroid hormone receptor B loci resulted in a peak lod score of 3.1 confirming linkage of VHL to this region of chromosome 3. However, the position of VHL relative to the two loci could not be established with certainty.

UI MeSH Term Description Entries
D008126 Lod Score The total relative probability, expressed on a logarithmic scale, that a linkage relationship exists among selected loci. Lod is an acronym for "logarithmic odds." Lod Scores,Score, Lod,Scores, Lod
D002893 Chromosomes, Human, Pair 3 A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification. Chromosome 3
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006623 von Hippel-Lindau Disease An autosomal dominant disorder caused by mutations in a tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions. Cerebelloretinal Angiomatosis, Familial,Lindau Disease,Angiomatosis Retinae,Familial Cerebello-Retinal Angiomatosis,Hippel-Lindau Disease,Lindau's Disease,VHL Syndrome,von Hippel-Lindau Syndrome,Angiomatoses, Familial Cerebello-Retinal,Angiomatoses, Familial Cerebelloretinal,Angiomatosis, Familial Cerebello-Retinal,Angiomatosis, Familial Cerebelloretinal,Cerebello-Retinal Angiomatoses, Familial,Cerebello-Retinal Angiomatosis, Familial,Cerebelloretinal Angiomatoses, Familial,Familial Cerebello Retinal Angiomatosis,Familial Cerebello-Retinal Angiomatoses,Familial Cerebelloretinal Angiomatoses,Familial Cerebelloretinal Angiomatosis,Hippel Lindau Disease,Lindau's Diseases,Lindaus Disease,VHL Syndromes,von Hippel Lindau Disease,von Hippel Lindau Syndrome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000798 Angiomatosis A condition with multiple tumor-like lesions caused either by congenital or developmental malformations of BLOOD VESSELS, or reactive vascular proliferations, such as in bacillary angiomatosis. Angiomatosis is considered non-neoplastic. Angiomatoses
D015342 DNA Probes Species- or subspecies-specific DNA (including COMPLEMENTARY DNA; conserved genes, whole chromosomes, or whole genomes) used in hybridization studies in order to identify microorganisms, to measure DNA-DNA homologies, to group subspecies, etc. The DNA probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the DNA probe include the radioisotope labels 32P and 125I and the chemical label biotin. The use of DNA probes provides a specific, sensitive, rapid, and inexpensive replacement for cell culture techniques for diagnosing infections. Chromosomal Probes,DNA Hybridization Probe,DNA Probe,Gene Probes, DNA,Conserved Gene Probes,DNA Hybridization Probes,Whole Chromosomal Probes,Whole Genomic DNA Probes,Chromosomal Probes, Whole,DNA Gene Probes,Gene Probes, Conserved,Hybridization Probe, DNA,Hybridization Probes, DNA,Probe, DNA,Probe, DNA Hybridization,Probes, Chromosomal,Probes, Conserved Gene,Probes, DNA,Probes, DNA Gene,Probes, DNA Hybridization,Probes, Whole Chromosomal

Related Publications

J M Vance, and K W Small, and M A Jones, and J M Stajich, and L H Yamaoka, and A D Roses, and W Y Hung, and M A Pericak-Vance
January 2018, Advances in experimental medicine and biology,
J M Vance, and K W Small, and M A Jones, and J M Stajich, and L H Yamaoka, and A D Roses, and W Y Hung, and M A Pericak-Vance
April 1993, Bratislavske lekarske listy,
J M Vance, and K W Small, and M A Jones, and J M Stajich, and L H Yamaoka, and A D Roses, and W Y Hung, and M A Pericak-Vance
June 2003, Lancet (London, England),
J M Vance, and K W Small, and M A Jones, and J M Stajich, and L H Yamaoka, and A D Roses, and W Y Hung, and M A Pericak-Vance
November 2005, Hereditary cancer in clinical practice,
J M Vance, and K W Small, and M A Jones, and J M Stajich, and L H Yamaoka, and A D Roses, and W Y Hung, and M A Pericak-Vance
November 1997, Medicine,
J M Vance, and K W Small, and M A Jones, and J M Stajich, and L H Yamaoka, and A D Roses, and W Y Hung, and M A Pericak-Vance
March 2000, Harefuah,
J M Vance, and K W Small, and M A Jones, and J M Stajich, and L H Yamaoka, and A D Roses, and W Y Hung, and M A Pericak-Vance
January 2009, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti,
J M Vance, and K W Small, and M A Jones, and J M Stajich, and L H Yamaoka, and A D Roses, and W Y Hung, and M A Pericak-Vance
June 2016, Journal of pediatric genetics,
J M Vance, and K W Small, and M A Jones, and J M Stajich, and L H Yamaoka, and A D Roses, and W Y Hung, and M A Pericak-Vance
March 2000, Mayo Clinic proceedings,
J M Vance, and K W Small, and M A Jones, and J M Stajich, and L H Yamaoka, and A D Roses, and W Y Hung, and M A Pericak-Vance
September 2006, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!